Metadata

Dataset ID: 16
Back to List

Study Design
Study Design Background Investigation of the tumor-homing properties of a chromogranin A-derived peptide containing an RGDL motif followed by a chemically stapled alpha-helix (called 5a)
Study Description Peptide 5a was labeled with IRDye 800CW or with 18F-NOTA
Study Type preclinical
Study Subtype in vitro, in vivo, ex vivo
Publication
Paper Linked yes
Paper Title A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins
Paper Authors Monieri M, Rainone P, Sacchi A, Gori A, Gasparri AM, Coliva A, Citro A, Ferrara B, Policardi M, Valtorta S, Pocaterra A, Alfano M, Sheppard D, Piemonti L, Moresco RM, Corti A, Curnis F
Affiliation Division of Experimental Oncology, San Raffaele, Milano, Italy
Paper Journal International Journal of Biological Sciences
Paper Year 2023
Paper Doi https://doi.org/10.7150/ijbs.76148
Open Access yes
Updated Year 2024
Study Component
Multi Modality Images yes
Imaging Modality PET/CT
Radiation yes
Imaging Coverage whole-body
Imaging Target αvβ6, αvβ8
Dataset Information
Institution IBSBC-CNR
Pi Angelo Corti
Country Of Institution Italy
Imaging Facility Laboratory of preclinical molecular imaging
Euro Bio Imaging Node MMMI
Country Of Imaging Facility Italy
Funding yes
Funding Agency Associazione Italiana per la Ricerca sul Cancro (AIRC)
Dataset Access limited
Duo Data Use Permission DUO:0000042
Duo Data Use Modifier DUO:0000046
Duo Investigation DUO:0000040
Contact Person paolo.rainone@unimib.it
In Vivo Experimental Parameters
Number Of Groups 2
Types Of Groups treated
Overall Sample Size 24
Disease Model cancer
Organ Or Tissue pancreas, prostate
Sample Size For Each Group 3, 4
Randomization yes, when tumors were palpable
Blinding no
Statistical Methods Anova
Species Mice
Strain NOD/scid, C57BL/6N, Nu/nu CD1, Balb/c
Immune Status Immunodeficient
Sex female and male
Age 8 week-old
Weight 30g
Genotype n/a
Genetic Manipulation n/a
Gene n/a
Source Of Animals Charles River Laboratories, Italy
Experimental Procedures
Pharmacological Procedures Intervention And Control no
Blood Sampling yes
Surgical Procedures Including Sham Surgery yes
Pathogen Infection Intervention And Control no
Analgesic Plan To Relieve Pain Suffering And Distress no
Anesthesia For Imaging yes
Anesthesia Type gas
Anesthesia Drugs isoflurane
Anesthesia Dose 2%
Monitoring Regime respiratoy, cardiac rate
Euthanasia yes
Method cervical dislocation
Histology yes
Tissues Collected Post Euthanasia Tumor and selected organs
Timing Of Collection end of study
Imaging yes
Frequency Of Imaging single scan
Timing Of Imaging 14 days
Contrast Agent Or Radio Isotope Or Challenge With Gas Molecule yes
Contrast Agent Commercial Drug 18F
Contrast Agent Chemical Drug Fluorine-18
Contrast Agent Dose 3.7 MBq
Injection Volume 0.05 - 0.1 ml
Route Of Administration intravenous
Cell Lines yes
Cell Line BxPC-3 pancreatic carcinoma, 5637 bladder carcinoma, MeWo, TRAMP-C2, BHY
Provenance ATCC, DSMZ
Image Acquisition
Instrument Vendor Molecubes
Instrument Type β-cube, X-cube
Instrument Specifics FOV size for PET 130X72 mm, FOV size for CT 37X65 mm
Correction decay correction
Raw Data yes
Image Correlation
Image Type processed image
Image Scale SUV for PET
Format Compression DICOM
Dimensions 3D
Overall Number Of Images 24
Field Of View Total body
Dimension Extents 192x192x384
Pixel Voxel Size Description 0.4x0.4x0.4
Image Processing Methods Image reconstruction
Image Reconstruction Algorithm OSEM
Quality Control n/a
Image Smoothing Or Filtering Algorithm n/a
Image Registration Algorithm n/a
Ai Enhanced Algorithm yes
Analyzed Data
Data Used For Analysis SUV, volume measurements
Status complete
Ontology Terms
Ncit Imaging NCIT:C103512
Doid DOID:162
Ncit Anatomy NCIT:C12410,NCIT:C12393
Ncit Species NCIT:C14238
Ncit Strain NCIT:C15167,NCIT:C37357
Chebi Anesthesia CHEBI:6015
Chebi Contrast Agent Commercial Name CHEBI:36939
Chebi Contrast Agent Chemical Name CHEBI:36939
Clo CLO:0002065,CLO:0001421
Back to List